Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Collaborate
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
About
About
EQOH
Careers
Contact Us
EMJ Gold
search
Join
FREE
You must accept all conditions before being able to view the post
Continue
EUR
USA
EUR
USA
Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Collaborate
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
About
About
EQOH
Careers
Contact Us
EMJ Gold
Join
FREE
6
Mins
4 Dec 2024
Interview: Roy Fleischmann
There are probably two main reasons. The first is that during medical school and my post-medical school training, the most dynamic…
4 Dec 2024
Remdesivir Lowers 30-Day COVID-19 Readmissions in Vulnerable Patients
A retrospective study highlighted the effectiveness of remdesivir in reducing 30-day COVID-19-related readmissions among vulnerable patient populations, including older adults and those with immunocompromising conditions.
4 Dec 2024
AI, Social Media, and Dermatology: A New Review
A newly published review sheds light on how the digital revolution is reshaping the field of cosmetic dermatology.
December 2024
AMJ Neurology 1 [Supplement 1]
Explore our latest article summarising key discussions from a symposium at the 40th Congress of the European Committee for…
7
Mins
4 Dec 2024
Ozanimod in Relapsing Multiple Sclerosis: New Insights
Ozanimod is a sphingosine 1-phosphate (S1P) receptor 1 and 5 (S1PR1 and S1PR5) modulator approved in multiple countries for the…
4 Dec 2024
Knee Pain Treatment with Colchicine Falls Short
Investigation into colchicine’s potential as a treatment for knee osteoarthritis (OA) found no significant improvement in pain or function in a recent study.
3 Dec 2024
Eosinophilic Inflammation in Focus: New Trial Data
Benralizumab, a monoclonal antibody targeting eosinophilic inflammation, outperformed prednisolone alone in treating acute exacerbations of asthma and COPD in a new study.
3 Dec 2024
Farming Lessons to Combat Cancer Resistance
Agricultural pest management methods were explored in a new study to determine how they can be adapted to combat cancer treatment resistance.
3 Dec 2024
Early Psychosis Detection In 5-Minute Scan
A functional brain biomarker that could revolutionize psychosis detection has been identified in a new study.
2 Dec 2024
Cigarette Smoke Disrupts Microbiota, Worsens Flu Severity
Chronic exposure to cigarette smoke (CS) may significantly worsen the severity of influenza A virus (IAV) infections, not only through direct lung damage but also via changes in the microbiota.
←
1
2
3
…
43
44
45
46
47
48
49
…
78
79
80
→
We’ve noticed you’re accessing
from
North/South America.
View
View